期刊文献+

细胞凋亡、增殖和Fas/FasL系统在大肠癌中的作用 被引量:1

Effect of Apoptosis,Proliferation and Fas/FasL System in Colorectal Carcinoma
暂未订购
导出
摘要 目的 :探讨细胞凋亡、增殖及相关基因Fas、FasL在大肠癌发生发展中的作用。方法 :用免疫组化SP法检测 4 0例大肠腺癌、15例腺瘤及 15例正常组织Fas、FasL、PCNA蛋白的表达 ,并以TUNEL法对相应标本行凋亡细胞检测。结果 :凋亡指数随肿瘤分化程度的降低呈下降趋势 ,与淋巴结转移相关 (P <0 .0 5 )。增殖指数随肿瘤分化程度的降低呈上升趋势 ,但与淋巴结转移无相关性 (P >0 .0 5 )。在正常粘膜、大肠腺瘤、大肠腺癌中Fas表达逐渐降低 ,FasL表达逐渐增高 ,均有显著性差异 (P <0 .0 5 )。结论 :Fas、FasL异常表达促使肿瘤细胞逃避自身免疫攻击 ,细胞凋亡、增殖的平衡失调及Fas FasL系统异常表达在大肠癌发生发展中起重要作用。 Objective: To investigate the role of apoptosis,PCNA and related genes Fas,FasL in the progression of colorectal carcinoma. Methods: The expression of Fas, FasL, PCNA protein were detected by immunohistochemical method in 15 cases of colorectal adenomas,40 cases of colorectal carcinomas and 15 cases of normal mucous. The TdT medated dUTP biotin nick and labeling (TUNEL) positive were counted in all cases as apoptosis index. Results: AI was higher in colorectal carcinoma than normal tissues and lower than colorectal adenoma. It was well correlated with the pathological grading and lymph node metastasis(P<0.05). PI was increased in whole procession, but it was not correlated with clinical pathologic characteristics (P>0.05). Fas was declined and FasL was increased in whole procession (P<0.05). Conclusion: The abnormal expression of Fas,FasL in colorectal carcinoma suggest that it is a mechanism of immune escape. The imbalance of cell apoptosis and proliferation takes part in the progression of colorectal carcinoma.
出处 《武汉大学学报(医学版)》 CAS 2003年第2期149-151,共3页 Medical Journal of Wuhan University
关键词 大肠肿瘤 细胞凋亡 细胞增殖 FAS/FASL colorectal carcinoma apoptosis cell proliferation Fas/FasL
  • 相关文献

同被引文献29

  • 1Webb SD, Sherratt JA, Fish RG. Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. Math Biosci 2002;179:113-129.
  • 2Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L, Stringaro A, Molinari A, Arancia G, Gentile M, Parmiani G, Fais S.Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002;195:1303-1316.
  • 3Li JH, Rosen D, Sondel P, Berke G. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology 2002;105:267-277.
  • 4Koyama S, Koike N, Adachi S. Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma. J Cancer Res Clin Oncol 2001;127:20-26.
  • 5Michael-Robinson JM, Pandeya N, Cummings MC, Walsh MD, Young JP, Leggett BA, Purdie DM, Jass JR, Radford-SmithG L. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. J Pathol 2003;201:46-54.
  • 6rHouston A, Waldron-Lynch FD, Bennett MW, Roche D,O'Sullivan GC, Shanahan F, O'Connell J. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo. Int J Cancer 2003;107:209-214.
  • 7Song E, Chen J, Ouyang N, Su F, Wang M, Heemann U. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer 2001;85:1047-1054.
  • 8Oka S, Tanaka S, Hiyama T, Kitadai Y, Yoshihara M,Shimamoto F, Haruma K, Chayama K. Human telomerase reverse transcriptase, p53 and Ki-67 expression and apoptosis in colorectal serrated adenoma. Scand J Gastroenterol 2002;37:1194-1200.
  • 9Choi C, Benveniste EN. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 2004;44:65-81.
  • 10Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res 2003;63:5573-5581.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部